Shows
MedEdTalks - OphthalmologyRecap with Dr. Rishi Singh: An Overview of Intravitreal Interventions, Volume, 10, Issue 1Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions, Volume, 10, Issue 12021-07-0908 minMedEdTalks - OphthalmologyPort Delivery System With Ranibizumab, With Nancy M. Holekamp, MD, and Arshad M. Khanani, MD, MAIn this podcast, expert clinicians will discuss best practices regarding the use of Port Delivery System with ranibizumab.2021-07-0118 minMedEdTalks - OphthalmologyAchieving Vascular Stability through Inhibition of Ang-2 in AMD and DME, With Nancy M. Holekamp, MD, and Carl D. Regillo, MD, FACSIn this podcast, expert clinicians will discuss achieving vascular stability through inhibition of Ang-2. To obtain CME credit, go here: https://tinyurl.com/y58538ef 2021-07-0118 minMedEdTalks - OphthalmologyEmerging Delivery Systems in Neovascular Retinal Disease: Focus on Gene Therapy, With Nancy M. Holekamp, MD, and Arshad M. Khanani, MD, MAIn this podcast, expert clinicians will discuss emerging gene therapies for AMD and DME. To obtain CME credit, go here: https://tinyurl.com/yusxpn44 2021-06-3019 minMedEdTalks - OphthalmologyEmerging Delivery Systems in Neovascular Retinal Disease: Focus on Devices, With Nancy M. Holekamp, MD, and Carl D. Regillo, MD, FACSIn this podcast, expert clinicians will discuss emerging delivery system devices in neovascular retinal disease. To obtain CME credit, please go here: https://tinyurl.com/thma9fwp2021-06-3015 minMedEdTalks - OphthalmologyCurbside Consults on Retinal Vein Occlusion Management: Treating RVO Early to Improve OutcomesRetinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden...2021-06-0220 minMedEdTalks - OphthalmologyCurbside Consults on Retinal Vein Occlusion Management: Use of Imaging in the Diagnosis of RVORetinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden...2021-06-0222 minMedEdTalks - OphthalmologyCurbside Consults on Retinal Vein Occlusion Management: Use of Imaging in Monitoring Treatment Response in RVORetinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden...2021-06-0218 minMedEdTalks - OphthalmologyCurbside Consults on Retinal Vein Occlusion Management: Deciphering New Data on RVO Treatment – How Do they Affect Real World Practice?Retinal vein occlusions (RVOs) are the second most common retinal vascular disorder after diabetic retinopathy. The early and accurate diagnosis of RVO is paramount so that therapy can be initiated in a timely manner to prevent vision decline. Newer imaging technologies integrated into current diagnostic algorithms are aiding in the diagnosis of RVO and guiding therapy. Further, significant visual and anatomic improvements have been demonstrated with anti-vascular endothelial growth factor (VEGF) therapies in patients with central or branch RVO-related macular edema, and refinement of treatment protocols have the potential to further enhance outcomes as well as reduce treatment burden...2021-06-0210 min
MedEdTalks - CardiologyPFO Closure: Procedural Pearls and Important Considerations with Drs. Herrmann, Carroll, and KasnerIn this podcast, expert clinicians will share procedural pearls for PFO closure and important considerations to optimize patient outcomes. 2021-04-2914 minMedEdTalks - CardiologyManaging Patients With Cryptogenic Stroke: Clinical Perspectives, with Drs. Herrmann, Carroll, and KasnerIn this podcast, expert clinicians will discuss management of patients with cryptogenic stroke as well as strategies for applying new guideline recommendations into practice.2021-04-2913 minMedEdTalks - CardiologyThe Relationship Between PFO and Cryptogenic Stroke: Reviewing the Data, with Drs. Herrmann, Carroll, and KasnerIn this podcast, expert clinicians will discuss the association between patent foramen ovale and stroke and review the current clinical data to support PFO closure.2021-04-2915 minMedEdTalks - CardiologyDiagnosis and Classification of Cryptogenic Stroke and PFO-Associated Stroke, with Drs. Herrmann, Carroll, and KasnerIn this podcast, expert clinicians will discuss strategies for classification and workup of cryptogenic stroke and PFO-associated stroke.2021-04-2916 min
MedEdTalks - DermatologyValuable Acne Management Resources for Patients and Providers With Drs. Linda Stein Gold and Jerry TanIn this podcast, expert clinicians will discuss valuable acne management resources for both patients and providers.2021-04-0817 minMedEdTalks - DermatologyImplementing Optimal Follow-up Care for Acne Management With Drs. Linda Stein Gold and Julie HarperIn this podcast, expert clinicians will discuss best practices for implementing optimal follow-up care for acne management.2021-04-0814 minMedEdTalks - DermatologyTaking a Patient-centered Approach to Evaluating and Selecting Acne Management Therapeutic Regimens With Drs. Linda Stein Gold and Julie HarperIn this podcast, expert clinicians will discuss best practices in selecting acne management while using a patient-centered approach.2021-04-0816 minMedEdTalks - DermatologyIncluding the Patient/Caregiver in Clinical Decision Making for Acne Management With Drs. Linda Stein Gold and Jerry TanIn this podcast, expert clinicians will discuss best practices in including the patient/caregiver in clinical decision making for acne management.2021-04-0830 minMedEdTalks - CardiologyRecent Cardiovascular Outcomes Trials: Reducing Triglycerides for Further Risk Reduction with Drs. Pamela Morris and Deepak BhattIn this podcast, expert clinicians will discuss latest clinical evidence from cardiovascular outcomes trials and how reducing triglycerides for further reduces risk.2021-03-2416 minMedEdTalks - CardiologyDeep Dive Into Clinical Evidence: Reducing CVD risk through LDL-C reduction with Drs. Pamela Morris and Ann Marie NavarIn this podcast, expert clinicians will discuss evidence regarding mitigating cardiovascular risk by LDL-C reduction.2021-03-2417 minMedEdTalks - CardiologyPatient Identification for Residual Risk Management: Who’s At Risk? with Drs. Pamela Morris and Martha GulatiIn this podcast, expert clinicians will discuss secondary prevention and how to identify patients who may benefit from additional treatment to reduce CV risk.2021-03-2411 minMedEdTalks - CardiologyStrategies for Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment: What’s the Risk? with Drs. Pamela Morris and Martha GulatiIn this podcast, expert clinicians discuss primary prevention as well as strategies for ASCVD risk assessment.2021-03-2415 min
MedEdTalks - GastroenterologyEfficacy and Safety of Anti-interleukin (IL) 23 and Janus Kinase (JAK) Inhibitors with Drs. William J. Sandborn and Jessica R. AllegrettiIn this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-IL-23 and JAK inhibitors, that are in late-stage development for treating moderate to severe CD.2021-03-1616 minMedEdTalks - GastroenterologyEfficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. SandbornIn this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-integrin and S1P-1 receptor modulators, that are in late-stage development for treating moderate to severe CD.2021-03-1615 minMedEdTalks - GastroenterologyMechanisms of Action of New Classes of Agents for Moderate to Severe Crohn’s Disease with Drs. William J. Sandborn and Bruce E. SandsIn this podcast, expert clinicians will discuss emerging therapies with unique mechanisms of action that can improve the treatment of moderate to severe Crohn’s disease.2021-03-1619 minMedEdTalks - OphthalmologyExploring Treatment Options for Neurotrophic Keratitis: A Challenging CaseIn this podcast, expert clinicians will discuss a challenging case in the treatment of neurotrophic keratitis.2021-01-2514 minMedEdTalks - OphthalmologyStaging and Diagnosing Neurotrophic Keratitis: A Challenging CaseIn this podcast, expert clinicians will discuss a challenging case in the staging and diagnosis of neurotrophic keratitis.2021-01-2513 minMedEdTalks - OphthalmologyExploring Treatment Options for Neurotrophic KeratitisIn this podcast, expert clinicians will discuss different treatment options for neurotrophic keratitis.2021-01-2513 minMedEdTalks - OphthalmologyDiagnosis and Staging of Neurotrophic KeratitisIn this podcast, expert clinicians will discuss pathophysiology, diagnosis, and staging of neurotrophic keratitis.2021-01-2516 minMedEdTalks - CardiologysGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed ButlerIn this podcast, expert clinicians will discuss the potential use of sGC modulators in the management of patients with heart failure with reduced ejection fraction (HFrEF).2020-12-1614 minMedEdTalks - CardiologyThe Clinical Evidence: Efficacy and Safety of sGC Modulators in Heart Failure With Reduced Ejection Fraction With Drs. Paul Armstrong and Javed ButlerIn this podcast, expert clinicians will discuss the safety and efficacy of sGC modulators that was seen in various clinical trials.2020-12-1614 minMedEdTalks - CardiologysGC Modulators: Unique Mechanism of Action and Rationale for Use in Heart Failure With Drs. Paul Armstrong and Carolyn LamIn this podcast, expert clinicians will discuss the mechanism of action of sGC modulators and the rationale for its use in patients with heart failure.2020-12-1611 minMedEdTalks - CardiologyHeart Failure Management: Guideline-directed Therapy and Unmet Needs With Drs. Paul Armstrong and Carolyn LamIn this podcast, expert clinicians will discuss the burden of heart failure in the United States and the potential of new therapies for treating heart failure.2020-12-1614 min
MedEdTalks - RheumatologyWhat Comes After Treat to Target? Listening to the Patient and the Role of Empathy With Drs. Cassandra Calabrese and Leonard CalabreseIn this podcast, expert clinicians will discuss the importance of empathy in caring for patients with rheumatic diseases. Key aspects of empathy such as listening, eye contact, and reading body language are included. Listen in as Drs. Len and Cassie Calabrese discuss the critical aspects of empathy for rheumatology providers. For CME Credit, complete activity here: https://tinyurl.com/Rheumatology32020-12-0212 minMedEdTalks - RheumatologyBest Practices for Optimizing Vaccine Administration in Rheumatology With Drs. Leonard Calabrese and Cassandra CalabreseIn this podcast series, expert clinicians will discuss optimal vaccine practices for rheumatology providers. Herpes zoster, influenza, and pneumococcal vaccine administration will be discussed. Listen in as Dr. Len and Cassandra Calabrese discuss important details on vaccination for rheumatology providers. For CME Credit, complete activity here: https://tinyurl.com/Rheumatology22020-12-0212 minMedEdTalks - RheumatologyImproving RA Outcomes Through Immune Wellness Education With Drs. Leonard Calabrese and M. Elaine HusniIn this podcast series, expert clinicians will discuss patient wellness and its importance for rheumatology providers. Key components of wellness such as diet, exercise, and sleep will be discussed. Listen in as Drs. Len Calabrese and Elaine Husni discuss why wellness is important for patients with rheumatic diseases. For CME Credit, complete activity here: https://tinyurl.com/Rheumatology12020-12-0217 minMedEdTalks - RheumatologyHerpes Zoster Vaccination in At-risk Populations: Patient Education and Management of Side Effects with Drs. Len Calabrese and Cassandra CalabreseIn this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Len Calabrese and Cassandra Calabrese review zoster vaccine side effects and patient education strategies to enhance vaccination rates. For CME Credit, complete activity here: https://tinyurl.com/HZ004 2020-11-0610 minMedEdTalks - RheumatologyCurrent State of Herpes Zoster Vaccination - Prevention Strategies With a Focus on Immune-mediated Disease with Drs. Len Calabrese and Paul SaxIn this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Calabrese and Sax review zoster vaccine safety and efficacy and discuss strategies for vaccination. For CME Credit, complete activity here: https://tinyurl.com/HerpZo3 2020-11-0614 minMedEdTalks - RheumatologyRisk Factors for Herpes Zoster- Important Considerations for Patients with Immune-mediated Diseases with Drs. Len Calabrese and Jeffrey CurtisIn this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Calabrese and Curtis discuss primary risk factors for HZ, incidence rates among patients with IMID, and optimized use of vaccines for these at-risk populations. For CME Credit, complete activity here: https://tinyurl.com/HZ002 2020-11-0516 minMedEdTalks - RheumatologyClinical Manifestations of Herpes Zoster- A Focus on Patients With Immune-mediated Disease with Drs. Len Calabrese and Cassandra CalabreseIn this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Len Calabrese and Cassandra Calabrese discuss the clinical manifestations of herpes zoster and potential sequelae. For CME Credit, complete activity here: https://tinyurl.com/HZ001 2020-11-0511 min
MedEdTalks - Primary CareDr. Citrome and Dr. Ospina Discuss the Importance of Team-based CareIn this podcast, expert clinicians will discuss multidisciplinary care approaches to consider in tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these novel therapies and the discrepancies in their use. The other episodes in this series will...2020-09-3014 minMedEdTalks - Primary CareDr. Citrome and Dr. Saklad Discuss Treatment Options for Tardive DyskinesiaIn this podcast, expert clinicians will discuss available therapies for tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these novel therapies and the discrepancies in their use. The other episodes in this series will cover the symptoms...2020-09-3014 minMedEdTalks - Primary CareDr. Citrome and Dr. Saklad Discuss the Burden of Tardive DyskinesiaIn this podcast, expert clinicians will discuss the burden of tardive dyskinesia (TD) on the patient and health care system. TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these novel therapies and the discrepancies in their use. The other episodes i...2020-09-3015 minMedEdTalks - Primary CareDr. Citrome and Dr. Ospina Discuss Background Information on Tardive DyskinesiaIn this podcast, expert clinicians will discuss the symptoms, pathology, and causes of tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these novel therapies and the discrepancies in their use. The other episodes in this series will...2020-09-3013 minMedEdTalks - OphthalmologySight-saving Therapeutics for the Treatment of Neovascular Age-Related Macular DegenerationIntravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment regimens have provided significant improvements to long-term visual outcomes in neovascular age-related macular degeneration (nAMD). However, some patients do not receive an optimal response with current anti-VEGF therapies, while poor adherence due to treatment burden remains a significant problem. Continuing advances in the refinement of dosing frequency protocols, as well as the development of therapies and devices that promise to extend dosing intervals, have the potential to overcome treatment burden, further enhancing long-term visual outcomes. Within this 4-part podcast series, experts in the field discuss current therapy dosing schedules and their impact...2020-07-2900 minMedEdTalks - OphthalmologyInterpreting the Latest Clinical Trial Results of New and Emerging Treatments for nAMDIntravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment regimens have provided significant improvements to long-term visual outcomes in neovascular age-related macular degeneration (nAMD). However, some patients do not receive an optimal response with current anti-VEGF therapies, while poor adherence due to treatment burden remains a significant problem. Continuing advances in the refinement of dosing frequency protocols, as well as the development of therapies and devices that promise to extend dosing intervals, have the potential to overcome treatment burden, further enhancing long-term visual outcomes. In this podcast, Dr. Arshad Khanani and Dr. Peter Kaiser interpret the latest clinical trial data of n...2020-07-2920 minMedEdTalks - OphthalmologyDosing Schedules for Emerging Agents Used to Treat nAMD That Require Less Frequent Dosing Than Standard Anti-VEGF TherapyIntravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment regimens have provided significant improvements to long-term visual outcomes in neovascular age-related macular degeneration (nAMD). However, some patients do not receive an optimal response with current anti-VEGF therapies, while poor adherence due to treatment burden remains a significant problem. Continuing advances in the refinement of dosing frequency protocols, as well as the development of therapies and devices that promise to extend dosing intervals, have the potential to overcome treatment burden, further enhancing long-term visual outcomes. In this podcast, Dr. Arshad Khanani and Dr. Nancy Holekamp discuss dosing schedules for emerging agents in t...2020-07-2917 minMedEdTalks - OphthalmologyNovel Mechanisms Beyond Anti-VEGF for Treatment of nAMDIntravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment regimens have provided significant improvements to long-term visual outcomes in neovascular age-related macular degeneration (nAMD). However, some patients do not receive an optimal response with current anti-VEGF therapies, while poor adherence due to treatment burden remains a significant problem. Continuing advances in the refinement of dosing frequency protocols, as well as the development of therapies and devices that promise to extend dosing intervals, have the potential to overcome treatment burden, further enhancing long-term visual outcomes. In this podcast, Dr. Arshad Khanani and Dr. Peter Kaiser discuss novel mechanisms beyond anti-VEGF for the t...2020-07-2916 minMedEdTalks - OphthalmologyDosing Schedules for Current Agents Used to Treat Neovascular Age-Related Macular Degeneration (nAMD)Intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment regimens have provided significant improvements to long-term visual outcomes in neovascular age-related macular degeneration (nAMD). However, some patients do not receive an optimal response with current anti-VEGF therapies, while poor adherence due to treatment burden remains a significant problem. Continuing advances in the refinement of dosing frequency protocols, as well as the development of therapies and devices that promise to extend dosing intervals, have the potential to overcome treatment burden, further enhancing long-term visual outcomes. In this podcast, Dr. Arshad Khanani and Dr. Nancy Holekamp discuss dosing schedules for current anti-VEGF agents u...2020-07-2914 minMedEdTalks - Primary CareTreating Influenza in Pediatric PatientsWhile the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the latest updates on the treatment of influenza. Transcript: https://tinyurl.com/influenza2-5 ...2020-07-1612 minMedEdTalks - Primary CareTreating Influenza in High-Risk PatientsWhile the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the latest updates on the treatment of influenza. Transcript: https://tinyurl.com/influenza2-42020-07-1611 minMedEdTalks - Primary CareSafety and Efficacy of Current Influenza TreatmentsWhile the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the latest updates on the treatment of influenza. Transcript: https://tinyurl.com/influenza2-3 ...2020-07-1609 minMedEdTalks - Primary CareTo Treat or Not to Treat? Deciding Factors Influencing Influenza ProphylaxisWhile the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the latest updates on the prophylaxis of influenza. Transcript: https://tinyurl.com/influenza2-2 ...2020-07-1610 minMedEdTalks - Primary CareAssessing Patients for Influenza InfectionWhile the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the latest updates on the diagnosis of influenza. Transcript: https://tinyurl.com/Influenza2-1 2020-07-1613 minMedEdTalks - Primary CareInfluenza Podcasts: Updates in Diagnosis and TreatmentWhile the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. 2020-07-1600 minMedEdTalks - OphthalmologyEffect of Subretinal Fluid on Visual Outcomes in Neovascular AMDThe integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Dante Pieramici discuss the effect of subretinal fluid on visual...2020-06-2914 minMedEdTalks - OphthalmologySustained Suppression of VEGF – What is the Effect? Where is the Evidence?The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Dante Pieramici discuss the potential effects of sustained vascular endothelial...2020-06-2916 minMedEdTalks - OphthalmologyEffective Treatment Interval Extensions in Neovascular Retinal DiseaseThe integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Charles Wykoff discuss effective treatment interval extensions in neovascular retinal...2020-06-2914 minMedEdTalks - OphthalmologyInhibition of Ang-2: Potential Effect in DME Treatment ParadigmsThe integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Jeffrey Heier discuss inhibition of angiopoietin-2 and its potential effect...2020-06-2914 minMedEdTalks - OphthalmologyInhibition of Ang-2: Potential Effect in AMD Treatment ParadigmsThe integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Jeffrey Heier discuss inhibition of angiopoietin-2 and its potential effect...2020-06-2913 minMedEdTalks - OphthalmologyDrug Delivery Systems in Neovascular Retinal DiseaseThe integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patient adherence. However, suboptimal responses to therapy along with loss of patient adherence from treatment burden has defined a need for the development of novel treatments and sustained delivery options for the management of neovascular retinal diseases. In this podcast, Dr. Carl Regillo and Dr. Charles Wykoff discuss emerging drug delivery systems for the management...2020-06-2915 minMedEdTalks - RheumatologyEGPA With ENT ManifestationsEosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the sinuses, lungs, gastrointestinal system, heart, and kidneys. Early diagnosis and treatment are critical when managing EGPA to improve patient outcomes and reduce symptom burden. Education is needed to provide clinicians with the latest information regarding optimal diagnostic and management strategies, including newer steroid-sparing therapy options. In this CME podcast series...2020-06-0110 minMedEdTalks - RheumatologyTreating Patient Who Are Refractory to or Dependent on GlucocorticoidsEosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the sinuses, lungs, gastrointestinal system, heart, and kidneys. Early diagnosis and treatment are critical when managing EGPA to improve patient outcomes and reduce symptom burden. Education is needed to provide clinicians with the latest information regarding optimal diagnostic and management strategies, including newer steroid-sparing therapy options. In this CME podcast series...2020-06-0111 minMedEdTalks - RheumatologyInitiating Treatment for EGPAEosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the sinuses, lungs, gastrointestinal system, heart, and kidneys. Early diagnosis and treatment are critical when managing EGPA to improve patient outcomes and reduce symptom burden. Education is needed to provide clinicians with the latest information regarding optimal diagnostic and management strategies, including newer steroid-sparing therapy options. In this CME podcast series...2020-06-0111 minMedEdTalks - RheumatologyDifferentiating EGPA from Related Eosinophilic DisordersEosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the sinuses, lungs, gastrointestinal system, heart, and kidneys. Early diagnosis and treatment are critical when managing EGPA to improve patient outcomes and reduce symptom burden. Education is needed to provide clinicians with the latest information regarding optimal diagnostic and management strategies, including newer steroid-sparing therapy options. In this CME podcast series...2020-06-0110 minMedEdTalks - RheumatologyImmunopathology and Clinical Presentation of EGPAEosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the sinuses, lungs, gastrointestinal system, heart, and kidneys. Early diagnosis and treatment are critical when managing EGPA to improve patient outcomes and reduce symptom burden. Education is needed to provide clinicians with the latest information regarding optimal diagnostic and management strategies, including newer steroid-sparing therapy options. In this CME podcast series...2020-06-0114 minMedEdTalks - RheumatologyGiant Cell Arteritis Curbside Consults: Diagnostic Challenges, Part IIIn this case-based podcast, Leonard H. Calabrese, DO, and Adam Brown, MD, discuss a patient who presents to the hospital with fever of unknown origin.2020-01-3112 minMedEdTalks - RheumatologyGiant Cell Arteritis Curbside Consults: Diagnostic Challenges, Part IIn this case-based podcast, Leonard H. Calabrese, DO, and Adam Brown, MD, discuss a patient presenting for a second opinion for GCA after initial workup and treatment by her primary care physician.2020-01-3113 minMedEdTalks - RheumatologyGiant Cell Arteritis Curbside Consults: Patient Presenting to the Emergency Department With New-Onset Visual SymptomsIn this case-based podcast, Leonard H. Calabrese, DO, and Ann P. Murchison, MD, MPH, discuss issues related to the workup, diagnosis, and treatment of a patient with new-onset visual symptoms presenting to the emergency department.2020-01-3114 minMedEdTalks - RheumatologyGiant Cell Arteritis Curbside Consults: A Patient With Complicated GCAIn this case-based podcast, Leonard H. Calabrese, DO, and Sebastian Unizony, MD, discuss issues related to the workup, diagnosis, and treatment of a patient with complicated GCA.2020-01-3115 minMedEdTalks - RheumatologyGiant Cell Arteritis Curbside Consults: A Patient With Uncomplicated GCAIn this case-based podcast, Leonard H. Calabrese, DO, and Sebastian Unizony, MD, discuss issues related to the workup, diagnosis, and treatment of a patient with uncomplicated, or “classic”, GCA.2020-01-3116 minMedEdTalks - RheumatologyGiant Cell Arteritis Curbside Consults: A Case-based “Micro-CME” SeriesGiant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. Despite new treatment options for patients with GCA, delays in diagnosis and treatment lead to poor outcomes, such as the increased risk for visual impairments and incidence of heart attacks, transient ischemic attacks, and/or mortality. Diagnosis of GCA remains difficult due to the nonspecific nature of many early symptoms. Until recently, therapeutic options were limited to prolonged, high-dose glucocorticoid therapy, which has the potential for many undesirable side effects. In this Curbside Consults series, expert faculty will discuss clinical cases that emphasize appropriate medical...2020-01-3100 minMedEdTalks - CardiologyCardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Blood Pressure Control and Optimizing Care Coordination and Medication ManagementIn this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss blood pressure control as well as optimizing care coordination and medication management in the patient with diabetes. Transcript: https://tinyurl.com/yj8zwh69 To earn CME credit, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-blood-pressure-control-and-optimizing-care-coordination-and-medication2020-01-0810 minMedEdTalks - CardiologyCardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Reducing CV Risk in Patients With Diabetes – A Discussion on the Latest DataIn this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss the latest data on reducing CV risk in patients with diabetes. Transcript: https://tinyurl.com/yeendrms To earn CME Credit, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-reducing-cv-risk-in-patients-with-diabetes-a-discussion-on-the-latest-data2020-01-0813 minMedEdTalks - CardiologyCardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; The Interplay Between T2DM and CV Risk – Implications for PatientsIn this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss the interplay between T2DM and CV risk. Transcript: https://tinyurl.com/yh9kt3al To earn CME credits, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-the-interplay-between-t2dm-and-cv-risk-implications-for-patients2020-01-0812 minMedEdTalks - CardiologyMedEd Talks in Cardiology - Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists2020-01-0801 min
MedEdTalks - NeurologyMS Forum VI: Applying the Latest Data and Advanced Communication to Individualize Treatment and Improve Quality CareMedEdTalks in Neurology is a Vindico Medical Education production. The following podcast series is supported by educational grants from Biogen; Celgene Corporation; EMD Serono, Inc.; Genentech, Inc.; and Sanofi Genzyme. Your host, Dr. Patricia Coyle will interview Drs. Bruce Cohen, Clyde Markowitz, and Claire Riley throughout the series. To earn CME/CNE credit, log into MedEdTalks.com and search “MS Forum® VI” or click the link in the notes section of each episode to go directly to that activity, take the test, and complete the evaluation. Before beginning this activity, please be sure to review the fa...2019-12-2000 minMedEdTalks - Primary CareEmerging Options for Refractory Chronic CoughThe diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. Michael Blaiss and Dr. Peter Dicpinigaitis discuss emerging therapeutic options for the management of patients with refractory chronic cough.2019-12-1007 minMedEdTalks - Primary CareChronic Cough – A Typical Patient JourneyThe diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. John Russell and Dr. Michael Blaiss discuss the initial steps for the evaluation and management of patients presenting with chronic cough.2019-12-1010 minMedEdTalks - Primary CareChronic Cough – Symptoms and BurdenThe diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this podcast, Dr. Michael Blaiss and Dr. John Russell define chronic cough, discuss its symptoms, and review the associated physical and psychological burden of patients with this condition.2019-12-1008 minMedEdTalks - RheumatologyANCA-Associated Vasculitis Management Strategies – Focus on GPA and MPAThis educational activity will discuss management strategies for ANCA-associated vasculitis, focusing on GPA and MPA.2019-10-2915 minMedEdTalks - RheumatologyANCA-Associated Vasculitis – Making the Accurate and Timely DiagnosisThis educational activity will provide insight into making an accurate and timely diagnosis of ANCA-associated vasculitis.2019-10-2915 minMedEdTalks - RheumatologyPemphigus Vulgaris – Management StrategiesThis educational activity will discuss treatment strategies for patients with pemphigus vulgaris.2019-10-2910 minMedEdTalks - RheumatologyPemphigus Vulgaris – Making the Timely and Accurate DiagnosisThis educational activity will provide insight into making a timely and accurate diagnosis of pemphigus vulgaris.2019-10-2812 minMedEdTalks - RheumatologyGiant Cell Arteritis – Management StrategiesIn this MedEdTalks Micro-CE podcast, Leonard H. Calabrese, DO, and John H. Stone, MD, MPH, discuss management strategies for Giant Cell Arteritis (GCA). 2019-10-2515 minMedEdTalks - RheumatologyGiant Cell Arteritis – Diagnosis and ProgressionIn this MedEdTalks Micro-CE podcast, Leonard H. Calabrese, DO, and John H. Stone, MD, MPH, discuss the diagnosis and natural history of Giant Cell Arteritis (GCA). 2019-10-2313 minMedEdTalks - Rheumatology3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - PSAIn this CME podcast, Dr. John Tesser and Dr. Jeffrey Kaine will discuss the diagnosis and treatment of psoriatic arthritis. To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_september/mededtalks-rheumatology-3rd-annual-awir-national-conference-immunology-bootcamp-psa/cme-information2019-10-1021 minMedEdTalks - RheumatologyMedEdTalks Rheumatology: 3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - axSpAIn this CME podcast, Dr. Grace Wright and Dr. Leonard Calabrese will discuss the diagnosis and management of axial spondyloarthritis. Transcript: https://m3.healio.com/~/media/hyperguides/mededtalks/transcripts/j271met008-wrightcalabrese-for-download.docx To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_september/mededtalks-rheumatology-3rd-annual-awir-national-conference-immunology-bootcamp-axspa/cme-information2019-09-3012 minMedEdTalks - RheumatologyMedEdTalks Rheumatology: 3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - Effective Patient ConversationsIn this CME podcast, Dr. Grace Wright and Dr. John Tesser will discuss effective conversations with patients. Transcript: https://m2.healio.com/~/media/hyperguides/mededtalks/transcripts/j271met007-tesserwright-for-download.docx To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_september/mededtalks-rheumatology-3rd-annual-awir-national-conference-immunology-bootcamp-epc/cme-information2019-09-3015 minMedEdTalks - RheumatologyMedEdTalks Rheumatology: 3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - LupusIn this CME podcast, Dr. Grace Wright and Dr. John Tesser will discuss the diagnosis and treatment of systemic lupus erythematosus. Transcript: https://m2.healio.com/~/media/hyperguides/mededtalks/transcripts/j271met006-wrighttesser-for-download.docx To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_september/mededtalks-rheumatology-3rd-annual-awir-national-conference-immunology-bootcamp-lupus 2019-09-3022 minMedEdTalks - RheumatologyMedEdTalks Rheumatology: 3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - BiosimilarsIn this CME podcast, Dr. Grace Wright and Dr. Jeffrey Kaine will discuss the utilization of biosimilars in rheumatoid arthritis. To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_september/mededtalks-rheumatology-3rd-annual-awir-national-conference-immunology-bootcamp-biosimilars/cme-information2019-09-3017 minMedEdTalks - RheumatologyMedEdTalks Rheumatology: 3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - RAIn this CME podcast, Dr. Grace Wright and Dr. Jeffrey Kaine will discuss the diagnosis and treatment of rheumatoid arthritis. To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_september/mededtalks-rheumatology-3rd-annual-awir-national-conference-immunology-bootcamp-ra2019-09-3021 minMedEdTalks - RheumatologyMedEdTalks Rheumatology: 3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - irAEsIn this CME podcast, Dr. Leonard Calabrese and Dr. Jeffrey Kaine will discuss immune checkpoint inhibitor therapy and related toxicities. Transcript: https://m1.healio.com/~/media/hyperguides/mededtalks/transcripts/j271met001-calabresekaine-for-download.docx To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_september/mededtalks-rheumatology-3rd-annual-awir-national-conference-immunology-bootcamp-iraes/cme-information2019-09-3016 minMedEdTalks - RheumatologyMedEdTalks Rheumatology: 3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - GCAIn this Micro-CME podcast, Dr. Leonard Calabrese and Dr. John Tesser will discuss the diagnosis and treatment of giant cell arteritis. Transcript: https://m2.healio.com/~/media/hyperguides/mededtalks/transcripts/j271met001-tessercalabrese-downloadable-script.docx To obtain CME Credit, please go here: https://cme.healio.com/mededtalks/rheumatology/2019/09_september/mededtalks-rheumatology-3rd-annual-awir-national-conference-immunology-bootcamp-gca/cme-information2019-09-3018 minMedEdTalks - OphthalmologyTargeting Treatment in Neovascular Retinal DiseaseIn this MedEdTalks micro-CE podcast, Rishi P. Singh, MD, and Arshad M. Khanani, MD, MA, discuss new findings about emerging therapies that target the angiopoietin/Tie2 pathway that may improve the treatment of neovascular retinal diseases. Transcript: https://bit.ly/38jWicU To obtain CME Credit, please go here: https://bit.ly/2nBqmhq 2019-09-2913 minMedEdTalks - OphthalmologyDrug Delivery in Neovascular Retinal DiseaseIn this MedEdTalks micro-CE podcast, Rishi P. Singh, MD, and Nancy M. Holekamp, MD, discuss delivery systems for neovascular retinal diseases, with a particular focus on age-related macular degeneration. Transcript: https://bit.ly/2PqSj5P To obtain CME credit, please go here: https://bit.ly/2mNmJVt2019-09-2916 minMedEdTalks - RheumatologyMedEdTalks in Rheumatology - 3rd Annual Association of Women in Rheumatology National Conference: Immunology BootcampIn this podcast series: John Tesser will be interviewing Leonard Calabrese on Giant Cell Arteritis Jeffrey Kaine will be interviewing Leonard Calabrese on irAEs… Jeffrey Kaine will be interviewing John Tesser on Psoriatic Arthritis… Grace Wright will be interviewing Jeffrey Kaine on Rheumatoid Arthritis… Jeffrey Kaine will be interviewing Grace Wright on Biosimilars… Grace Wright will be interviewing John Tesser on Systemic Lupus Erythematosus… John Tesser will be interviewing Grace Wright on Effective Patient Conversation and… Grace Wright will be interviewing Leonard Calabrese on Axial Spondyloarthritis. 2019-09-2601 minMedEdTalks - GastroenterologyInvestigational Agents in Ulcerative Colitis: IL-12 and IL-23 InhibitorsInvestigational Agents in Ulcerative Colitis: IL-12 and IL-23 InhibitorsInflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, Dr. Peter Higgins and Dr. David Rubin will discuss investigational interleukin-12 and interleukin-23 inhibitors for treating UC. For the transcript of this podcast, click here. To obt...2019-04-2912 minMedEdTalks - GastroenterologyInvestigational Agents in Ulcerative Colitis: JAK Inhibitors and S1P Receptor ModulatorsInflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, Dr. Peter Higgins and Dr. William Sandborn will discuss investigational Janus kinase inhibitors and sphingosine-1-phosphate receptor modulators for treating UC. For the transcript of this podcast, click here. To obtain CME credit, click her...2019-04-2909 minMedEdTalks - GastroenterologyAnti-Integrin OverviewInflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, Dr. David Rubin and Dr. Peter Higgins will discuss investigational anti-integrin therapies for UC. For the transcript of this podcast, click here To obtain CME credit, click here2019-04-2509 minMedEdTalks - GastroenterologyUlcerative Colitis: Targeting Immunological Pathways in Moderate to Severe Disease – Updates From CopenhagenInflammatory bowel disease, which includes ulcerative colitis (UC) and Crohn’s disease, affects an estimated 3 million adults in the United States. Although numerous therapies are available for the treatment of moderate to severe UC, many patients still suffer poor quality of life and suboptimal outcomes. Therefore, safer and more effective UC therapies are needed. In this CME podcast activity, expert physicians will discuss investigational UC therapies with various mechanisms of action. For the full CME activity, click here2019-04-2500 min